×
Yubo Biotech Common Stock Net 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
View More
Yubo Biotech Common Stock Net 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$206.8B
Intuitive Surgical (ISRG)
$191.3B
Alcon (ALC)
$42.9B
Edwards Lifesciences (EW)
$38.8B
IQVIA Holdings (IQV)
$38.8B
IDEXX Laboratories (IDXX)
$34.9B
DexCom (DXCM)
$29B
Waters (WAT)
$22.9B
STERIS (STE)
$22B
SONOVA HOLDING (SONVY)
$21.6B
Hologic (HOLX)
$18.5B
Sysmex ADR (SSMXY)
$12.6B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Globus Medical (GMED)
$11.3B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.9B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.6B
TransMedics (TMDX)
$3.1B
Inari Medical (NARI)
$3B
Veracyte (VCYT)
$3B
LivaNova (LIVN)
$2.9B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.3B